April 7 (Reuters) - Marvel Biosciences Corp MRVL.V:
MARVEL BIOSCIENCES SECURES FINANCIAL AND STRATEGIC INVESTMENT WITH 5 HORIZON VENTURES
MARVEL BIOSCIENCES CORP - 5 HORIZONS VENTURES TO FUND 15% OF CRO COSTS FOR PHASE I MB-204 TRIAL
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.